WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002008273) 47508, A NOVEL HUMAN HISTONE DEACETYLASE FAMILY MEMBER AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2002/008273 International Application No.: PCT/US2001/023153
Publication Date: 31.01.2002 International Filing Date: 23.07.2001
Chapter 2 Demand Filed: 19.02.2002
IPC:
A61K 38/00 (2006.01) ,C12N 9/16 (2006.01)
Applicants: MEYERS, Rachel, E.[US/US]; US (UsOnly)
MILLENNIUM PHARMACEUTICALS, INC.[US/US]; 75 Sidney Street Cambridge, MA 02139, US (AllExceptUS)
Inventors: MEYERS, Rachel, E.; US
Agent: ALLEN, Theodore, R.; Millennium Pharmacueticals, Inc. 75 Sidney Street Cambridge, MA 02139-4169, US
Priority Data:
60/220,00821.07.2000US
Title (EN) 47508, A NOVEL HUMAN HISTONE DEACETYLASE FAMILY MEMBER AND USES THEREOF
(FR) 47508, UN NOUVEAU MEMBRE DE LA FAMILLE DE L'HISTONE DEACETYLASE HUMAINE ET UTILISATIONS ASSOCIEES
Abstract: front page image
(EN) The invention provides isolated nucleic acids molecules, designated 47508 nucleic acid molecules, which encode novel human histone deacetylase members. The invention also provides antisense nucleic molecules, recombinant expression vectors containing 47508 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 47508 gene has been introduced or disrupted. The invention still further provides isolated 47508 proteins, fusion proteins, antigenic peptides and anti-47508 antibodies. Diagnostic methods utilizing compositions of the invention are aslo provided.
(FR) L'invention concerne des molécules d'acides nucléiques isolées appelées molécules d'acides nucléiques 47508, codant pour des nouveaux membres de la famille de l'histone deacetylase humaine. L'invention concerne également des molécules d'acides nucléiques antisens, des vecteurs d'expression de recombinaison contenant les molécule d'acides nucléiques 47508, des cellules hôtes dans lesquelles des vecteurs d'expression ont été introduits, et des animaux transgéniques non humains dans lesquels le gène 47508 a été introduit ou interrompu. L'invention concerne également des protéines 47508 isolées, des protéines hybrides, des peptides antigéniques et des anticorps anti-47508. En outre, l'invention concerne des méthodes diagnostiques utilisant les compositions décrites dans la présente invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)